ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

37,607Medicare Part D Prescriptions Filled, Including Refills

Rank: 11 out of 6969

$3.71M Total Retail Price of All Prescriptions

Rank: 4 out of 6969

515 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
100% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

11% of this provider’s 515 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 36,284 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

54% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$99 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

73 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
NEXIUM 1,444 1,356 1 52
LIDODERM 1,215 1,150 2 75
ATENOLOL 1,161 1,114 3 9
DIOVAN 1,003 969 4 26
AMLODIPINE BESYLATE 982 942 5 4
ZOLPIDEM TARTRATE 850 814 6 16
CELEBREX 831 790 7 67
CREON 825 790 10 8 147
CRESTOR 797 763 9 39
SIMVASTATIN 779 763 10 1
LEVOTHYROXINE SODIUM 744 712 11 5
LOVAZA 706 682 12 77
DIOVAN HCT 701 678 13 57
ZETIA 694 669 14 98
DONEPEZIL HCL 672 665 15 32
TRAMADOL HCL 635 601 16 27
ATORVASTATIN CALCIUM 615 602 17 11
NAMENDA 548 535 18 51
FUROSEMIDE 548 537 18 10
LOSARTAN-HYDROCHLOROTHIAZIDE 530 523 20 53
ROPINIROLE HCL 472 472 21 162
MELOXICAM 446 432 22 36
METFORMIN HCL 439 420 23 7
CAPTOPRIL 432 401 24 226
MECLIZINE HCL 430 416 25 100
LOSARTAN POTASSIUM 421 421 26 12
ACIPHEX 415 399 10 27 181
OMEPRAZOLE 409 402 28 6
METOPROLOL SUCCINATE 376 370 29 22
VESICARE 366 354 30 163
VOLTAREN 347 347 31 105
ADVAIR DISKUS 339 318 32 45
PANTOPRAZOLE SODIUM 335 330 33 31
CYMBALTA 331 319 34 72
ISOSORBIDE MONONITRATE ER 329 312 35 81
ESCITALOPRAM OXALATE 328 323 36 93
SYNTHROID 301 301 37 94
ALLOPURINOL 296 281 38 35
GLIMEPIRIDE 274 273 39 44
PLAVIX 265 258 40 68
FLECTOR 259 245 10 41 264
KLOR-CON 8 250 242 42 104
TAMSULOSIN HCL 249 234 43 23
LIPITOR 247 247 44 89
CLOPIDOGREL 245 242 45 48
METOPROLOL TARTRATE 240 221 46 13
LEXAPRO 233 216 47 200
BENICAR 228 213 48 107
NASONEX 223 207 49 144
BYSTOLIC 218 204 50 155
EVISTA 217 217 51 118
SINGULAIR 217 208 51 84
ACTONEL 196 183 53 115
ACTOS 189 187 54 61
NITROSTAT 186 185 55 210
AMIODARONE HCL 176 176 56 184
JANUVIA 174 173 57 41
BENICAR HCT 173 168 58 176
LISINOPRIL 172 146 59 2
WARFARIN SODIUM 172 172 59 20
DEXILANT 168 165 61 110
CLONIDINE HCL 164 164 62 59
FAMOTIDINE 164 164 62 37
GLYBURIDE 164 162 R 62 54
ACETAMINOPHEN-CODEINE 163 162 S3 65 73
SERTRALINE HCL 163 163 65 38
CARVEDILOL 163 163 65 25
MICARDIS HCT 161 148 68 285
CILOSTAZOL 159 159 69 208
VYTORIN 155 142 70 148
NIFEDIPINE ER 152 152 71 95
ENALAPRIL MALEATE 146 136 72 56
AMLODIPINE BESYLATE-BENAZEPRIL 145 145 73 91
AMITIZA 130 129 74 254
TEKTURNA 129 128 75 295
NAPROXEN 129 111 75 62
IBUPROFEN 128 115 77 29
CARBIDOPA-LEVODOPA 123 123 78 119
IBANDRONATE SODIUM 118 101 79 178
NITROLINGUAL 117 116 10 80 440
MICARDIS 115 115 81 277
PRAVASTATIN SODIUM 111 111 82 19
HYDROCODONE-ACETAMINOPHEN 111 111 S3 82 3
JANUMET 110 103 84 138
LEVOFLOXACIN 109 107 85 109
ZALEPLON 107 107 86 515
CITALOPRAM HBR 105 99 87 34
HYDROCHLOROTHIAZIDE 104 97 88 8
RANITIDINE HCL 104 104 88 46
DETROL LA 103 103 90 223
LUNESTA 100 99 91 374
PROAIR HFA 100 92 91 33
ALENDRONATE SODIUM 98 98 93 14
MONTELUKAST SODIUM 91 81 94 151
VERAPAMIL ER 89 79 95 133
SOLARAZE 88 88 96 314
DILTIAZEM 24HR CD 87 87 97 191
BENAZEPRIL HCL 87 85 97 18
LANSOPRAZOLE 85 84 99 171
GABAPENTIN 84 84 100 17
RAMIPRIL 83 74 101 112
EXELON 76 75 102 157
AVODART 73 60 103 108
TERAZOSIN HCL 73 73 103 49
AZITHROMYCIN 69 68 105 42
VALSARTAN-HYDROCHLOROTHIAZIDE 67 62 106 346
PROMETHAZINE HCL 65 64 R 107 203
POTASSIUM CHLORIDE 65 62 107 30
BUSPIRONE HCL 65 65 107 187
SURE COMFORT ALCOHOL 63 63 110 269
PAROXETINE HCL 63 63 110 65
LEVOXYL 61 61 112 122
ISOSORBIDE DINITRATE 60 60 113 231
PROCTOZONE-HC 59 58 114 293
PIOGLITAZONE HCL 59 54 R 114 174
TRICOR 58 58 116 143
NISOLDIPINE 57 49 117 579
FINASTERIDE 57 57 117 80
PROCHLORPERAZINE MALEATE 56 55 119 328
DICLOFENAC SODIUM 55 52 120 78
TRIAMCINOLONE ACETONIDE 55 55 120 55
DILTIAZEM HCL 55 55 120 342
TRIAMTERENE-HCTZ 53 53 123 58
VENTOLIN HFA 52 40 124 125
ULORIC 51 43 125 243
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 9, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.